Chao Gao

4PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 28, 2026
The PON1-NDUFA4 axis maintains mitochondrial respiratory fitness and drives lenvatinib tolerance in hepatocellular carcinoma.

|Jun 02, 2025
The MASTL/YBX1/PAK4 axis regulated by stress-activated STK24 triggers lenvatinib resistance and tumor progression in HCC.

Bu-Gang Liang, Yi-Min Zheng, Ming-Hao Xu

|Apr 24, 2025
Cancer-derived exosomal circTMEM56 enhances the efficacy of HCC radiotherapy through the miR-136-5p/STING axis.

Li Yuan, Yue Wang, Junjie Cheng

|Dec 17, 2024
Anti-inflammatory effect of nestorone in a lipopolysaccharide-induced acute lung injury model through regulation of the TLR-4/Myd88/NF-κB signaling pathway.

Aying Ma, Jieyun Zhou, Hui Zou

Pageof 1

Frequent Collaborators

2 joint publications

Aiwu Ke

1 joint publications

Shisuo Du

1 joint publications

Bu-Gang Liang

1 joint publications

Yi-Min Zheng